These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25082853)

  • 1. Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys.
    Barret O; Hannestad J; Alagille D; Vala C; Tavares A; Papin C; Morley T; Fowles K; Lee H; Seibyl J; Tytgat D; Laruelle M; Tamagnan G
    J Nucl Med; 2014 Oct; 55(10):1712-8. PubMed ID: 25082853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Evaluation of
    Zhou X; Boellaard R; Ishiwata K; Sakata M; Dierckx RAJO; de Jong JR; Nishiyama S; Ohba H; Tsukada H; de Vries EFJ; Elsinga PH
    J Nucl Med; 2017 May; 58(5):762-767. PubMed ID: 28062599
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization in humans of 18F-MNI-444, a PET radiotracer for brain adenosine 2A receptors.
    Barret O; Hannestad J; Vala C; Alagille D; Tavares A; Laruelle M; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
    J Nucl Med; 2015 Apr; 56(4):586-91. PubMed ID: 25698783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vivo Evaluation of Fluorine-18 and Iodine-123 Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine Derivatives as PET and SPECT Radiotracers for Mapping A2A Receptors.
    Vala C; Morley TJ; Zhang X; Papin C; Tavares AA; Lee HS; Constantinescu C; Barret O; Carroll VM; Baldwin RM; Tamagnan GD; Alagille D
    ChemMedChem; 2016 Sep; 11(17):1936-43. PubMed ID: 27407017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupancy of adenosine A
    Ishibashi K; Miura Y; Wagatsuma K; Toyohara J; Ishiwata K; Ishii K
    Neuropharmacology; 2018 Dec; 143():106-112. PubMed ID: 30253174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Evaluation of an Adenosine A
    Sakata M; Ishibashi K; Imai M; Wagatsuma K; Ishii K; Zhou X; de Vries EFJ; Elsinga PH; Ishiwata K; Toyohara J
    J Nucl Med; 2017 Sep; 58(9):1464-1470. PubMed ID: 28280214
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo evaluation of [(123)I]MNI-420: a novel single photon emission computed tomography radiotracer for imaging of adenosine 2A receptors in brain.
    Tavares AA; Batis J; Barret O; Alagille D; Vala C; Kudej G; Koren A; Cosgrove KP; Nice K; Kordower JH; Seibyl J; Tamagnan GD
    Nucl Med Biol; 2013 Apr; 40(3):403-9. PubMed ID: 23332393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of [
    Zhou X; Khanapur S; de Jong JR; Willemsen AT; Dierckx RA; Elsinga PH; de Vries EF
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):577-589. PubMed ID: 26917190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation Dosimetry of a Novel Adenosine A
    Zhou X; Elsinga PH; Khanapur S; Dierckx RA; de Vries EF; de Jong JR
    Mol Imaging Biol; 2017 Apr; 19(2):289-297. PubMed ID: 27539309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic modeling, test-retest, and dosimetry of 123I-MNI-420 in humans.
    Tavares AA; Batis JC; Papin C; Jennings D; Alagille D; Russell DS; Vala C; Lee H; Baldwin RM; Zubal IG; Marek KL; Seibyl JP; Barret O; Tamagnan GD
    J Nucl Med; 2013 Oct; 54(10):1760-7. PubMed ID: 23970369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression.
    Hodgson RA; Bertorelli R; Varty GB; Lachowicz JE; Forlani A; Fredduzzi S; Cohen-Williams ME; Higgins GA; Impagnatiello F; Nicolussi E; Parra LE; Foster C; Zhai Y; Neustadt BR; Stamford AW; Parker EM; Reggiani A; Hunter JC
    J Pharmacol Exp Ther; 2009 Jul; 330(1):294-303. PubMed ID: 19332567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654.
    Barret O; Thomae D; Tavares A; Alagille D; Papin C; Waterhouse R; McCarthy T; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
    J Nucl Med; 2014 Aug; 55(8):1297-304. PubMed ID: 24898025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preladenant, a selective A(2A) receptor antagonist, is active in primate models of movement disorders.
    Hodgson RA; Bedard PJ; Varty GB; Kazdoba TM; Di Paolo T; Grzelak ME; Pond AJ; Hadjtahar A; Belanger N; Gregoire L; Dare A; Neustadt BR; Stamford AW; Hunter JC
    Exp Neurol; 2010 Oct; 225(2):384-90. PubMed ID: 20655910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D
    Barret O; Zhang L; Alagille D; Constantinescu CC; Sandiego C; Papin C; Sullivan JM; Morley T; Carroll VM; Seibyl J; Chen J; Lee C; Villalobos A; Gray D; McCarthy TJ; Tamagnan G
    J Nucl Med; 2021 Sep; 62(9):1307-1313. PubMed ID: 33579806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain adenosine A2A receptor occupancy by a novel A1/A2A receptor antagonist, ASP5854, in rhesus monkeys: relationship to anticataleptic effect.
    Mihara T; Noda A; Arai H; Mihara K; Iwashita A; Murakami Y; Matsuya T; Miyoshi S; Nishimura S; Matsuoka N
    J Nucl Med; 2008 Jul; 49(7):1183-8. PubMed ID: 18552135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of developing adenosine A
    LeWitt PA; Aradi SD; Hauser RA; Rascol O
    Parkinsonism Relat Disord; 2020 Nov; 80 Suppl 1():S54-S63. PubMed ID: 33349581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body biodistribution and dosimetry estimates of a novel radiotracer for imaging of serotonin 4 receptors in brain: [¹⁸F]MNI-698.
    Tavares AA; Caillé F; Barret O; Papin C; Lee H; Morley TJ; Fowles K; Holden D; Seibyl JP; Alagille D; Tamagnan GD
    Nucl Med Biol; 2014; 41(5):432-9. PubMed ID: 24674817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
    Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
    J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.
    Constantinescu CC; Tresse C; Zheng M; Gouasmat A; Carroll VM; Mistico L; Alagille D; Sandiego CM; Papin C; Marek K; Seibyl JP; Tamagnan GD; Barret O
    Mol Imaging Biol; 2019 Jun; 21(3):509-518. PubMed ID: 30084043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preladenant, a novel adenosine A(2A) receptor antagonist for the potential treatment of parkinsonism and other disorders.
    Salamone JD
    IDrugs; 2010 Oct; 13(10):723-31. PubMed ID: 20878595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.